A late-breaking study presented today at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical ...
Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...
The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...
Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate ...
GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...
Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate ...
Aortic valve disease, particularly calcific aortic valve disease (CAVD), is a significant health concern characterized by the thickening and calcification of the aortic valve leaflets. This ...
Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...
Patients with low-gradient aortic stenosis and reduced LVEF, compared with patients with high-gradient aortic stenosis, have worse clinical outcomes.
SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve ...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”) ...
Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.